Influenza pandemic: A perspective

Prehospital and Disaster Medicine

Volumn 24, Issue 6, 2009, Pages 473-477

  Seynaeve, Geert ^a  

^a Prehospital and Disaster Medicine   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DISASTER PLANNING; ECONOMICS; EDITORIAL; EPIDEMIC; HEALTH; HUMAN; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS A H1N1; INTERNATIONAL COOPERATION; STATISTICAL MODEL; STATISTICS;

DISASTER PLANNING; DISEASE OUTBREAKS; HUMANS; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERNATIONALITY; LOGISTIC MODELS; WORLD HEALTH;

EID: 77951631207     PISSN: 1049023X     EISSN: 19451938     Source Type: Journal    
DOI: 10.1017/S1049023X00007378     Document Type: Review

References (70)

1. Seynaeve G: The 1999 dioxin and Coca Cola crisis. A case study in Public Health Crises. Brussels, Belgium. Ecomed 2003.
2. Murray CJL, Lopez AD: Evidence-based health polk)'-Lessons from the global burden of disease study. Science 1996;274:740-743.
3. World Health Organization: The World Health Report 2008: Geneva: WHO, 2008.
4. International Federation of Red Cross and Red Crescent: The World Disasters Report 2000. Focus on Public Health. Geneva: 1FRC, 2000, p 240.
5. World Health Organization (WHO): The World Health Report 2008: Primary health Care. Now More Than Ever. Geneva: WHO, 2008.
6. Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030.PLoS Med 2006;3(11):2011-2030.
7. Norris JN: Social inequalities undiminished. Amstelveen, The Netherlands. TSoc Geneeskunde 1980,58 Suppl:13-18.
8. Knobloch J, Finke EJ, Domres B: Seuchenhygien and Bekampfung. In: Schutzkommission beim Bundesminister des Innern. Katastrophenmedizin. Leitfaden Jiir die drtzliche Versorgung im Katastrophenfall. Berlin: Auflage, 2002, pp 180-223.
9. Sasse J: Biologische Gefahren. Beitrage zum Bevolkerungsschutz. Bonn, BBK: Germany: 200S, p 394.
10. Oshitani H: Lessons learned from international responses to severe acute respiratory syndrome (SARS). Environmental Health and Preventive Medicine 2005;10(5):251-254.
11. Monson RR: Occupational Epidemiology. 2d ed. Boca Raton, Florida:CRC Press 1990, pp 1-12.
12. Lindeboom GA: Inledingto degeschiedenis dergeneeskunde. [Introduction in the history of medicine]. 7th ed. Rotterdam, The Netherlands: Erasmus Publishing, pp 251-252.
13. Zylberstein JC (ed): Rapport de la Commission d'Enquete sur relit des Connaisssances Scientifiques et les Actions Menies a Vigardde la Transmission du SIDA. Paris: Union Generate d'Editions, 1993, p 559.
14. Fan HY, Conner RF, Villareal LP: AIDS: Science and Society. Fifth Edition. Sudbury, Massachusetts: Jones and Bartlett Publishers, 2007, p 249.
15. Tucker JB: Scourge: The Once and Future Threat of Smallpox. New York: Adantic Mondy Press, 2001, p 291.
16. Kolata G: Flu: The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus that Caused It. New York: Simon 8c Schuster Adult Publishing Group, 2001, p 352.
17. Barry JM: The Great Influenza: The Epic Story of the Deadliest Plague in History. Viking Books: New York, 2004, p 546.
18. Johnson NP, Mueller J: Updating the accounts: Global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 2002;76;1Q5-U5.
19. US Homeland Security Council: National Strategy for Pandemic Influenza. Implementation Plan. One Year Summary. Washington: DHS, 2007, p 36.
20. Gorner P: New England Journal of Medicine Eases Conflict-of-interest Policy for Authors. Chicago Tribune, 13 June 2002.
21. Topol EJ, Nurok M, Ratain MJ, Sheridan ME, Lo B, Wolf L, Mccrary SV, Mccullough LB, Brody BA, Martin JB, Kasper DL: Conflict-of-interest policies. N Engl J Med 2001;344:1017-1018.
22. Parascandola M: A turning point for conflicts of interest: The controversy over the National Academy of Sciences' First Conflicts of Interest Disclosure Policy. JCO 2007;25:3774-3779.
23. Rothman DJ, McDonald WJ, Berkowitz CD: Professional medical associations and their relationships with industry: A proposal for controlling conflict of interest. JAMA 2009;301:1367-1372.
24. Tripathi S: Not just for profit, or not just? As the Swiss drug company behind Tamiflu comes under pressure to allow clones, Salil Tripathi asks whether bargain-basement copies really help. The Guardian 04 November 2005.
25. Russell S: Biotech firm wants to regain control of avian flu drug. Gilead says deal with Roche Inc. threatens Tamiflu's production. San Francisco Chronicle 24 June 2005.
26. Wachman R: Roche poised for £ bn deal on bird flu drugs. Companies boost production of anti-virals for national stockpiles. The Observer UK 27 October 2005.
27. Mathiason N: Roche makes a killing. As panic spreads over the avian flu, the Swiss pharmaceutical giant is accused of putting profits before people. The Observer UK23 October 2005.
28. Beaumont P, Hinsliff G: WMD: How it went wrong. Since David Kay's bombshell last week, intelligence experts are revealing the truth behind Saddam's threat to the West. The Observer 01 February 2004.
29. Lean G, Owen J: Donald Rumsfeld makes $5m killing on bird flu drug. The Independent, UK 12 March 2006.
30. Hayden FG, Palese P: Influenza Virus In: Richmman DD, Whidey RJ, Hayden FG (eds). Clinical Virology. New York: Churchill Livingstone, 1997, pp 911-942.
31. Seynaeve G: Pandemic Influenza Preparedness Planning. Report on the 4th Joint EC/ECDC/WHO Workshop on Pandemic Influenza Preparedness. Luxembourg, 25-27 September 2007. Copenhagen, Denmark, WHO Regional Office for Europe, 2007, p 46.
32. Assaad F, Borecka I: Nine-year study of WHO virus reports on fatal virus infections. Bull WHO 1977;55(4):445-453.
33. Assaad F, Cockburn WC: A seven-year study of WHO virus laboratory reports on respiratory virusses. Bull WHO 1974;51(5):427-445.
34. Christie AB: Infectious Diseases. Epidemiology and Clinical Practice. 2d ed. New York: Churchil Livingstone, 1974, pp 316,326-331, 336-338.
35. Boix E: Grippe. In: Brissaud E, Pinard A, Reclus P (eds), Pratique Midico-Chirurgicale. Tome III. Paris: Masson et Cie Editeurs, 1907, pp 371-394.
36. Rubin EH: Diseases of the Chest. With Emphasis on X-Ray Diagnosis. PhUadelphia: WB Saunders, 1948, pp 102-108.
37. Friedwald WF: Influenza. In: Harrison TR (edit), Principles of Internal Medicine. Second Edition. New York,Toronot, London: McGraw-Hill Book Cy, 1954, pp 1079-1081.
38. Lyght CE (ed): The Merck Manual of Diagnosis and Therapy. 9th edition. Rahway, NJ: Merck & Co Inc., 1956, pp 866-870.
39. Horsfall FL: Influenza. In: Cecil RL, Loeb RF: A Textbook of Medicine. 9th Ed. Philadelphia, London: W.B. Saunders, 1957, pp 9-13.
40. Lilington GA, Jamplis RW: A Diagnostic Approach to Chest Diseases: Differential Diagnoses based on Roentgenographic Patterns. Baltimore: Williams & Wilkins Cy, 1965, pp 163-164,206-207,299-301,309-311,791-794.
41. Mosby's Comprehensive Review of Nursing. 7th Ed. Saint Louis: The C.V. Mosby Cy, 1969, pp 443,458.
42. Beland IL: Clinical Nursing: Pathophysiological and Psychosocial Approaches. 2d Ed. London: Coffier-Macmillan Ltd, 1970, pp 110-149,297.
43. Brainerd H, Krupp MA, Chatton MJ, Margen S: Current Diagnosis and Treatment. Los Altos, California: Lange Medical Publications, 1970, pp 677-678.
44. Wagner RB: Influezna. In: Wintrobe MM (ed): Harrisons Principles of Internal Medicine. 6th Ed. New York, Toronto, London: McGraw-Hill Book Cy, 1970, pp. 956-959.
45. Daven Port FM: Influenza Viruses. In: Evans AS: Viral Infections of Humans. Epidemiology and Control. London, New York, Sydney, Toronto: John Wiley & Sons, 1976, pp 273-296.
46. Parlemuter L, Cenac A: Dictionnaire pratique de Midecine Clinique. Paris: Masson, 1977, pp 52-60.
47. Simon HV: Respiratory Viral Infections. In: Medicine. Scientific American, 1994, pp 1-8.
48. Tierney LM, McPhee SJ, Papadakis MA (ed): Current Medical Diagnosis and Treatment. 39th Ed. New York Lange Medical Books/McGraw-Hill, 2000, pp 1321-1323.
49. Hampton T: Drug,vaccine research target avian &U.JAMA 2007;297:1179-1180.
50. MacDonald N: H1N1 influenza vaccine: Global access for a global problem. CM#2009;181(3-4):123.
51. National Strategy for Pandemic Influenza: Implementation Plan. One Year Summary. Homeland Security Council, July 2007, p 36.
52. De Goojer AC: De Spaanse griep van '18. [The Spanish Flu of '18.]. Amsterdam, The Netheralnds: Philips-Duphar, 1978, p 235.
53. Plotkin JB, DushoffJ: Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc Nat Acad 2003;100(12):7152- 7157.
54. Palese P, Tumpey TM, Garcia-Sastre A: What can we learn from econstruct-ing the extinct 1918 pandemic influenza virus? Immunity 2006;24(2):121-124.
55. Shann F: Pneumococcus and Influenza. In: [Need authors or editors] Modem Vaccines. Current Practice and New Approaches. A Lancet Review. London, Melbourne, Auckland: Edward Aarnold, 1990, pp 87-90.
56. Ajjan N: La vaccination. 2d Ed. Paris: Institut Mdriex, 1985, pp 64-65, 124-126,136-137,263-276.
57. Vogt D: Schutzimpfungen. In: Theopold W (editor), Prdventive Medizin. Frankfurt Am Main, Germany: Umschau Vcrlag, 1970, pp 153.
58. De Wit GA, Verweij A, Van Baal PHM, Vijgen SMC, Van Den Berg M, Busch MCM, Bamhoom MJM, Schuit AJ: Economic evaluation of prevention: Further evidence. RIVM Report 270091004/2007. Available at http^/rivm.openreposito-ry. com/rivm/bitstream/10029/16478/l/270091004.pdf. Accessed 18 December 2009.
59. US Preventive Services Task Force: Guide to Clinical Preventive Services. 2d Ed. Baltimore: Williams & Wilkins, 1996, pp 791-794.
60. Turner D, Wailoo A, Nicholson K, Coopers N, Sutton A, Abrams K: Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Techno! Assess 2003;7(35):286.
61. Benenson AS: Infectious Diseases. In: Levine S, Lilienfeld AM (edit), Epidemiology and Health Policy. New York-London: Tavistock Publications, 1987.
62. Gatherer D: The 2009 H1N1 influenza outbreak in its historical context. Journal of Clinical Virology 2009;45:174-178.
63. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, Miller MA: Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009;361:674-679.
64. Centers for Disease Control and Prevention: Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR 2009;58:400-402.
65. Zimmer SM, Burke DS: Historical perspective-Emergence of influenza A (H1N1) viruses. N Engl J Med 2009;361:279-285
66. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu Xiyan, Lindstrom S, Gubareva LV, Deyde V, Garten RJ, Harris M, Gerber S, Vagasky S, Smith F, Pascoe N, Martin K, Dufficy Deborah, Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS, Finellie L: Triple-Reassortant Swine Influenza A (HI) in Humans in the United States, 2005-2009. N Engl J Med 2009;360:2616-2625.
67. Pariente J: Pour Marc Gentilini, on assiste a une "panddmie de l'inddcence". Le Monde, France, August 6,2009.
68. Hak E, Meijboom MJ, Buskens E: Modelling the health-economic impact of the next influenza pandemic in The Netherlands. Vaccine 2006;24:6756-6760.
69. Sondervorst FA: Geschiedenis van de geneeskunde in Belgie. [History of Medicine in Belgium]. Brussel, Belgium: Elsevier, 1981, p 230.
70. Kovner AVR, Martin SP: Community Health and Medical Care. New York, San Francisco, London: Grune & Stratton Inc., 1978, p 483.